Browsing: Biosciences

IGM Biosciences, Inc.’s (NASDAQ:) Chief Financial Officer, Tahir Misbah, recently sold 1,487 shares of the company stock on September 13,…

IGM Biosciences, Inc. (NASDAQ:IGMS) CEO and President Fred Schwarzer recently sold a portion of his company shares, according to a…

In a recent transaction, Bruce Keyt, the Chief Scientific Officer of IGM Biosciences, Inc. (NASDAQ:), sold 1,487 shares of the…

IGM Biosciences, Inc. (NASDAQ: IGMS) recently disclosed a transaction involving Mary Beth Harler, the company’s Head of Research & Autoimmunity.…

Edward T. Mathers, a director and significant shareholder of MBX Biosciences, Inc. (NASDAQ:MBX), recently bolstered his investment in the company…

Recent filings show that an insider at MBX Biosciences, Inc. (NASDAQ:MBX), a pharmaceutical company specializing in novel therapeutics, has made…

An insider at MBX Biosciences, Inc. (NASDAQ:MBX), a pharmaceutical company specializing in therapeutic treatments, recently made a significant purchase of…

NEA 17, a major shareholder in MBX Biosciences, Inc. (NASDAQ:MBX), recently made a significant purchase of the company’s stock. The…

MBX Biosciences, Inc. (NASDAQ:MBX) executives, specializing in pharmaceutical preparations, have recently purchased a significant amount of the company’s common stock.…

In a recent transaction, executives from OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, and OrbiMed Genesis GP LLC collectively…